This announcement is a separate document:
復宏漢霖：(1)以吸收合併復宏漢霖之方式由復星新藥對復宏漢霖私有化之建議(2)建議撤銷復宏漢霖H股上市(3)臨時股東大會通告及(4)H股類別股東大會通告
HENLIUS: (1) PROPOSED PRIVATISATION OF HENLIUS BY FOSUN NEW MEDICINE BY WAY OF MERGER BY ABSORPTION OF HENLIUS (2) PROPOSED WITHDRAWAL OF LISTING OF THE H SHARES OF HENLIUS (3) NOTICE OF THE EXTRAORDINARY GENERAL MEETING AND (4) NOTICE OF THE H SHAREHOLDERS' CLASS
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.